Health Canada Approves Moderna’s RSV Vaccine for Adults 60 and Older
Moderna announced that Health Canada has approved mRESVIA™ (Respiratory Syncytial Virus mRNA vaccine) for the prevention of lower respiratory tract disease caused by RSV in adults aged 60 and older.…
Essential Facts About OTC Phenylephrine for Cold and Flu Season
Last fall, the Food and Drug Administration (FDA) recommended discontinuing the use of oral phenylephrine in over-the-counter (OTC) cold and cough products due to concerns over its effectiveness. This decision…
Royalty Pharma Acquires $125 Million Royalty Stake in Geron’s Rytelo
Royalty Pharma plc (Nasdaq: RPRX) announced an agreement to acquire a synthetic royalty on U.S. sales of Geron Corporation’s (Nasdaq: GERN) RYTELO, with a $125 million upfront cash payment. Approved…
AskBio’s AB-1003 Granted FDA Rare Pediatric Disease and Orphan Drug Designations
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company fully owned and operated as a subsidiary of Bayer AG, announced that its investigational gene therapy, AB-1003 (also known as LION-101), has…
Gilead Presents Late-Breaking Data at HIV Glasgow, Advancing Efforts to End the Epidemic
Gilead Sciences, Inc. (Nasdaq: GILD) has announced the upcoming presentation of over 40 HIV research studies at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2024), taking…
Allergan Aesthetics Marks Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Celebration
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is gearing up for the sixth annual BOTOX® Cosmetic Day, set for Wednesday, November 20, 2024. This special day celebrates the healthcare providers…
AstraZeneca Highlights Strength of Hematology Portfolio and Pipeline at ASH 2024
AstraZeneca will present new data from its cutting-edge hematology portfolio and pipeline at the 66th American Society of Hematology (ASH) Annual Meeting, taking place from December 7 to 10, 2024.…
WuXi Biologics Achieves AAA MSCI ESG Rating for the Second Consecutive Year
WuXi Biologics (“WuXi Bio”) (2269.HK), a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has received an AAA rating from Morgan Stanley Capital International (MSCI) ESG Ratings…
UNICEF and WHO Announce Completion of Second Round of Polio Campaign in Gaza Amid Ongoing Conflict
Second Round of Polio Vaccination Campaign in Gaza Completed Amid Ongoing Conflict: UNICEF and WHO The second round of the polio vaccination campaign in the Gaza Strip concluded yesterday, with…
Vaccine Doses Assigned to 9 African Countries Affected by Mpox Surge
The Access and Allocation Mechanism (AAM) for mpox has allocated an initial 899,000 vaccine doses to nine African countries severely impacted by the ongoing mpox outbreak. This distribution, made in…
Joint Statement from the WHO Director-General and the WHO Civil Society Task Force on Tuberculosis
The recently released Global Tuberculosis Report 2024 provides an updated overview of the challenges and progress in the global fight against tuberculosis (TB) during 2023. TB affected 10.8 million people…
Sarepta Therapeutics Reports Third Quarter 2024 Financial Results and Key Corporate Updates
Sarepta Therapeutics a leader in precision genetic medicine for rare diseases, has announced its financial results for the third quarter of 2024, showcasing strong revenue growth and significant progress in…